Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 15, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Primary human papillomavirus testing in organized cervical screening.

Joakim Dillner1

  • 1Department of Laboratory Medicine, Karolinska Institutet, Center for Cervical Cancer Prevention, Karolinska Hospital, Stockholm, Sweden. joakim.dillner@ki.se

Current Opinion in Obstetrics & Gynecology
|January 10, 2013
PubMed
Summary

Human papillomavirus (HPV) testing offers longer protection than cytology for cervical cancer screening, allowing extended intervals for HPV-negative women. Primary HPV screening is more cost-effective, though implementation requires addressing logistical challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selenite modulates phenotype-dependent epithelial-mesenchymal plasticity in pancreatic ductal adenocarcinoma: integrated in vitro analyses and patient-derived ex vivo tissue-slice cultures.

Journal of experimental & clinical cancer research : CR·2026
Same author

Global Performance of Human Papillomavirus Typing, Screening, and Evaluation As Assessed Using Proficiency Panels Traceable to International Standards: A Retrospective Analysis, 2008-2024.

Journal of medical virology·2026
Same author

Design principles and core components of cervical screening registries in the human papillomavirus era: a narrative review and global framework.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Repeat invitations and participation in cervical screening: A population-based cohort study.

Journal of medical screening·2026
Same author

HPV self-sampling for cervical cancer screening during wartime: a pilot implementation study from a conflict-affected region of Ukraine.

BMJ global health·2026
Same author

International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical Screening.

Journal of medical virology·2026

Area of Science:

  • Oncology
  • Public Health
  • Molecular Diagnostics

Background:

  • Cervical cancer screening is crucial for early detection and prevention.
  • Traditional screening relies on cervical cytology, which has limitations in detection and duration of protection.
  • Human papillomavirus (HPV) testing has emerged as a promising alternative for cervical cancer screening.

Purpose of the Study:

  • To provide an update on the utilization of HPV testing as a primary screening method.
  • To evaluate the effectiveness and cost-efficiency of HPV testing in organized cervical screening programs.
  • To identify challenges and opportunities for implementing HPV-based screening.

Main Methods:

  • Review of current literature and guidelines on HPV testing in cervical screening.

More Related Videos

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Related Experiment Videos

Last Updated: May 15, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

  • Analysis of comparative effectiveness and cost-effectiveness studies of HPV testing versus cytology.
  • Examination of logistical considerations for implementing HPV-based screening programs.

    • Main Results:

    • HPV-based screening provides longer-lasting protection compared to cytology, enabling extended screening intervals for HPV-negative individuals.
    • Primary HPV screening is generally more cost-effective than cytology-based screening.
    • Triage with cytology for HPV-positive results does not increase colposcopy referral rates.
    • Implementation challenges include standardizing HPV tests, ensuring correct usage at extended intervals and age groups, and quality assurance.

    Conclusions:

    • Organized, invitational screening programs possess the infrastructure to leverage HPV testing for enhanced cost-efficiency.
    • Piloting HPV screening, ideally through randomized healthcare policies, is feasible within existing programs.
    • Successful implementation requires addressing logistical hurdles and optimizing the transition to HPV-based methods.